Wells Fargo & Company Spring Works Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 148,168 shares of SWTX stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148,168

Previous 154,849 4.31%

Holding current value

$5.36 Million

Previous $5.83 Million 18.62%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$32.04 - $42.76 $214,059 - $285,679	-6,681 Reduced 4.31%	148,168 $4.75 Million
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $1.81 Million - $2.4 Million	50,328 Added 48.15%	154,849 $5.83 Million
Q1 2024 May 10, 2024	BUY	$36.5 - $52.5 $229,512 - $330,120	6,288 Added 6.4%	104,521 $5.14 Million
Q4 2023 Feb 09, 2024	SELL	$18.94 - $37.24 $593,920 - $1.17 Million	-31,358 Reduced 24.2%	98,233 $3.59 Million
Q3 2023 Nov 13, 2023	SELL	$23.12 - $31.38 $535,806 - $727,231	-23,175 Reduced 15.17%	129,591 $3 Million
Q2 2023 Aug 15, 2023	BUY	$23.15 - $32.71 $1.07 Million - $1.52 Million	46,382 Added 43.6%	152,766 $4.01 Million
Q1 2023 May 12, 2023	BUY	$24.97 - $34.05 $1.17 Million - $1.6 Million	46,932 Added 78.94%	106,384 $2.74 Million
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $133,596 - $176,570	-6,148 Reduced 9.37%	59,452 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $126,621 - $208,373	-5,254 Reduced 7.42%	65,600 $1.87 Million
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $258,967 - $847,287	-14,105 Reduced 16.6%	70,854 $1.75 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $25,905 - $34,628	-529 Reduced 0.62%	84,959 $4.8 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $1.2 Million - $1.71 Million	22,576 Added 35.89%	85,488 $5.3 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $1.48 Million - $2.08 Million	23,566 Added 59.89%	62,912 $3.99 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $1.44 Million - $1.83 Million	21,395 Added 119.19%	39,346 $3.24 Million
Q1 2021 May 13, 2021	SELL	$65.1 - $93.59 $1.03 Million - $1.49 Million	-15,890 Reduced 46.95%	17,951 $1.32 Million
Q4 2020 Feb 09, 2021	BUY	$48.36 - $77.92 $931,607 - $1.5 Million	19,264 Added 132.15%	33,841 $2.45 Million
Q3 2020 Nov 05, 2020	SELL	$36.14 - $51.99 $94,939 - $136,577	-2,627 Reduced 15.27%	14,577 $694,000
Q2 2020 Aug 13, 2020	BUY	$22.98 - $48.57 $243,059 - $513,724	10,577 Added 159.6%	17,204 $723,000
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $135,455 - $273,098	6,627 New	6,627 $179,000

Others Institutions Holding SWTX

# of Institutions

240

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.26B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Spring Works Therapeutics, Inc. Transaction History